Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Announced Late Friday: On January 19, 2024, Ideaya Biosciences Entered Into An Open Market Sales Agreement With Jefferies, Under Which The Company May Offer And Sell Shares Of Its Common Stock With Aggregate Gross Proceeds Of Up To $350M

Author: Charles Gross | January 20, 2024 11:10am

-8-K

Posted In: IDYA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist